Novaccess Global Inc (XSNX)
0.0065
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Novaccess Global Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2019 | -0.0897 |
| December 31, 2018 | -0.0746 |
| September 30, 2018 | -0.052 |
| June 30, 2018 | -0.0349 |
| March 31, 2018 | -0.1894 |
| December 31, 2017 | -0.2593 |
| September 30, 2017 | -0.2503 |
| June 30, 2017 | -0.3035 |
| March 31, 2017 | -0.2939 |
| December 31, 2016 | -0.2975 |
| September 30, 2016 | -0.3497 |
| June 30, 2016 | -0.374 |
| March 31, 2016 | -0.4237 |
| December 31, 2015 | -0.3201 |
| September 30, 2015 | -0.2586 |
| June 30, 2015 | -0.4044 |
| March 31, 2015 | -0.2657 |
| December 31, 2014 | -0.4056 |
| September 30, 2014 | -0.2781 |
| June 30, 2014 | -0.3036 |
| March 31, 2014 | -0.2502 |
| December 31, 2013 | -0.2239 |
| September 30, 2013 | -0.0946 |
| June 30, 2013 | -0.5758 |
| March 31, 2013 | -0.5331 |
| Date | Value |
|---|---|
| December 31, 2012 | -0.6401 |
| September 30, 2012 | -2.74 |
| June 30, 2012 | -2.464 |
| March 31, 2012 | -0.7298 |
| December 31, 2011 | -0.7798 |
| September 30, 2011 | -0.869 |
| June 30, 2011 | -1.728 |
| March 31, 2011 | -1.689 |
| December 31, 2010 | -0.7829 |
| September 30, 2010 | -1.090 |
| June 30, 2010 | -2.564 |
| March 31, 2010 | 1.040 |
| December 31, 2009 | 1.356 |
| September 30, 2009 | 0.9464 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.0173M |
| Total Liabilities (Quarterly) | 6.446M |
| Shareholders Equity (Quarterly) | -6.429M |